Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Reference Lab Analyzes Cancers From Patients

By HospiMedica staff writers
Posted on 28 Dec 2004
A specialty reference laboratory utilizes discoveries from the Human Genome Project to analyze cancers from individual patients.

Called the Molecular Profiling Institute Inc. More...
(MPI), the laboratory was formed by the Translational Genomics Research Institute (Tgen) and the International Genomics Consortium (IGC), all based in Phoenix (AZ, USA). MPI's first molecular profile program, called Target Now, is available to cancer patients for whom all standard therapies have failed. These patients can have their cancer sampled, profiled, and assessed to determine if one or more drug targets can be identified in their tumor tissue. MPI has formed a strategic partnership with AmeriPath, a leading U.S. anatomic pathology laboratory, whereby AmeriPath will use MPI for its advanced esoteric reference lab and provide assistance with co-marketing and sales.

MPI has also entered into an initial licensing agreement with Agendia (Amsterdam, The Netherlands), whereby MPI is the sole provider in the United States of MammaPrint, a microarray assay used to provide important prognostic information for women with early invasive breast cancer.

"By identifying the individual molecular profile of a person's cancer, MPI helps oncologists and pathologists to provide better customized therapeutic options for their patients,” noted Robert J. Penny, M.D., Ph.D., president and CEO of MPI.



Related Links:
Translational Genomics
International Genomics Research Inst.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Manual Pipetting Aid
Pipette Controllers macro
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.